Preparing for the future with the right debt financing

Deal Flash

Ace Pharmaceuticals (Ace) has been acquired by a consortium of Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and Ace’s management. Financing for this acquisition has been provided by ABN AMRO Bank, ASR and Rabobank.

As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making scarce medication available for people for whom this is essential.

The COVID-19 pandemic has clearly highlighted the challenges and gaps in our industry in Europe. It makes our mission to make scarce medicines available more important than ever. We want to respond to this situation strongly by growing organically as well as through acquisitions in Europe. With the capital, know-how and broad international network of Gilde Buy Out Partners, Gilde Healthcare and our existing investor Quadrum Capital, we can achieve this in both a socially responsible and financially sound manner. JAN WILLEM POPMA, DIRECTOR, ACE PHARMACEUTICALS, NETHERLANDS

Oaklins assists in establishing the right financing package

Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with its current business profile and future growth ambitions.

Talk to our advisors

Bas Stoetzer Amsterdam, Netherlands
Partner
View profile

Jeroen Derkx Amsterdam, Netherlands
Director
View profile

Niels Vermuë Amsterdam, Netherlands
Associate
View profile

Read more about the transaction, market trends, deal drivers and M&A valuation aspects

Oaklins Debt Advisory Deal Flash ACE Pharmaceuticals Mar2021 Last ned PDF